Syncom Formulations (India) Limited (SYNCOMF) - Total Liabilities
Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has total liabilities worth Rs775.88 Million INR (≈ $8.39 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Syncom Formulations (India) Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Syncom Formulations (India) Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Syncom Formulations (India) Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Syncom Formulations (India) Limited balance sheet assets.
Syncom Formulations (India) Limited Competitors by Total Liabilities
The table below lists competitors of Syncom Formulations (India) Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Avita Medical Inc
AU:AVH
|
Australia | AU$69.39 Million |
|
ST.GEORGE MINING LTD
F:S0G
|
Germany | €998.48K |
|
Inscobee
KO:006490
|
Korea | ₩48.82 Billion |
|
Capstone Energy Plus, Inc. Common Stock
NASDAQ:CEPL
|
USA | $85.10 Million |
|
In The F
KO:014990
|
Korea | ₩76.36 Billion |
|
Gulf Island Fabrication Inc
NASDAQ:GIFI
|
USA | $52.42 Million |
|
Iron Force Industrial Co Ltd
TW:2228
|
Taiwan | NT$1.98 Billion |
|
SOL-GEL TECHN. IS-10
F:4SG
|
Germany | €5.66 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Syncom Formulations (India) Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Syncom Formulations (India) Limited to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Syncom Formulations (India) Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Syncom Formulations (India) Limited (2006–2025)
The table below shows the annual total liabilities of Syncom Formulations (India) Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs711.23 Million ≈ $7.69 Million |
-39.39% |
| 2024-03-31 | Rs1.17 Billion ≈ $12.69 Million |
-3.66% |
| 2023-03-31 | Rs1.22 Billion ≈ $13.17 Million |
+41.62% |
| 2022-03-31 | Rs860.17 Million ≈ $9.30 Million |
-17.34% |
| 2021-03-31 | Rs1.04 Billion ≈ $11.25 Million |
+198.41% |
| 2020-03-31 | Rs348.73 Million ≈ $3.77 Million |
-13.57% |
| 2019-03-31 | Rs403.49 Million ≈ $4.36 Million |
-17.70% |
| 2018-03-31 | Rs490.26 Million ≈ $5.30 Million |
-21.96% |
| 2017-03-31 | Rs628.18 Million ≈ $6.79 Million |
-5.83% |
| 2016-03-31 | Rs667.07 Million ≈ $7.21 Million |
+78.45% |
| 2015-03-31 | Rs373.82 Million ≈ $4.04 Million |
-16.63% |
| 2014-03-31 | Rs448.40 Million ≈ $4.85 Million |
+27.51% |
| 2013-03-31 | Rs351.66 Million ≈ $3.80 Million |
+20.70% |
| 2012-03-31 | Rs291.34 Million ≈ $3.15 Million |
-7.24% |
| 2011-03-31 | Rs314.08 Million ≈ $3.40 Million |
-15.73% |
| 2010-03-31 | Rs372.72 Million ≈ $4.03 Million |
+68.09% |
| 2009-03-31 | Rs221.74 Million ≈ $2.40 Million |
-23.40% |
| 2008-03-31 | Rs289.48 Million ≈ $3.13 Million |
+46.94% |
| 2007-03-31 | Rs197.01 Million ≈ $2.13 Million |
+9.15% |
| 2006-03-31 | Rs180.49 Million ≈ $1.95 Million |
-- |
About Syncom Formulations (India) Limited
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more